Gross, histologic, and gene expression characteristics of osteoarthritic articular cartilage of the metacarpal condyle of horses

American Journal of Veterinary Research

Volumn 67, Issue 8, 2006, Pages 1299-1306

  Smith, Katie J ^a,b   Bertone, Alicia L ^a   Weisbrode, Stephen E ^a   Radmacher, Michael ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GLYCOSAMINOGLYCAN; MATRIX PROTEIN; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ARTICULAR CARTILAGE; CHONDROPATHY; CLINICAL FEATURE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC CODE; GENETIC CORRELATION; GENETIC DIFFERENCE; GENETIC IDENTIFICATION; HISTOPATHOLOGY; HORSE DISEASE; METACARPAL BONE; METACARPOPHALANGEAL JOINT; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PHOTOGRAPHY; PROTEIN FUNCTION; RNA PROCESSING; STATISTICAL ANALYSIS; TISSUE SECTION;

ANIMALS; CARTILAGE, ARTICULAR; FORELIMB; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HORSE DISEASES; HORSES; OSTEOARTHRITIS;

ANIMALIA; EQUIDAE;

EID: 33747785938     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.67.8.1299     Document Type: Article

References (46)

1. McIlwraith CW. General pathobiology of the joint and response to injury. In: McIlwraith CW, Trotter GW, eds. Joint disease in the horse. Philadelphia: WB Saunders Co, 1996;40-69.
2. Frisbie DD, Ghivizzani SC, Robbins PD, et al. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther 2002;9:12-20.
3. Malemud CJ, Islam N, Haqqi TM. Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 2003;174:34-48.
4. Young AA, Smith MM, Smith SM, et al. Regional assessment of articular cartilage gene expression and small proteoglycan metabolism in an animal model of osteoarthritis. Arthritis Res Ther [serial online]. 2005;7:R852-R861. Available at: arthritis-research.com/content/7/4/R852. Accessed Dec 27, 2005.
5. Wang J, Verdonk P, Elewaut D, et al. Homeostasis of the extracellular matrix of normal and osteoarthritic human articular cartilage chondrocytes in vitro. Osteoarthritis Cartilage 2003;11:801-809.
6. Pelletier JP, Martel-Petellier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001;44:1237-1247.
7. Hembry RM, Dyce J, Driesang I, et al. Immunolocalization of matrix metalloproteinases in partial-thickness defects in pig articular cartilage. A preliminary report. J Bone Joint Surg Am 2001:83-A:826-838.
8. Lo MY, Kim HT. Chondrocyte apoptosis induced by collagen degradation: inhibition by caspase inhibitors and IGF-1. J Orthop Res 2004;22:140-144.
9. Kuhn K, D'Lima DD, Hashimoto S, et al. Cell death in cartilage. Osteoarthritis Cartilage 2004;12:1-16.
10. Schuerwegh AJ, Dombrecht EJ, Stevens WJ, et al. Influence of pro-inflammatory (IL-1 alpha, IL-6, TNF-alpha, IFN-gamma) and anti-inflammatory (IL-4) cytokines on chondrocyte function. Osteoarthritis Cartilage 2003;11:681-687.
11. Dumond H, Presle N, Pottie P, et al. Site specific changes in gene expression and cartilage metabolism during early experimental osteoarthritis. Osteoarthritis Cartilage 2004;12:284-295.
12. Gehrsitz A, McKenna LA, Soder S, et al. Isolation of RNA from small human articular cartilage specimens allows quantification of mRNA expression levels in local articular cartilage defects. J Orthop Res 2001;19:478-481.
13. Tchetina EV, Squires G, Poole AR. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. J Rheumatol 2005;32:876-886.
14. Le Graverand MP, Eggerer J, Vignon E, et al. Assessment of specific mRNA levels in cartilage regions in a lapine model of osteoarthritis. J Orthop Res 2002;20:535-544.
15. Martin I, Jakob M, Schafer D, et al. Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Osteoarthritis Cartilage 2001;9:112-118.
16. Fehr JE, Trotter GW, Oxford JT, et al. Comparison of Northern blot hybridization and a reverse transcriptase-polymerase chain reaction technique for measurement of mRNA expression of metalloproteinases and matrix components in articular cartilage and synovial membrane from horses with osteoarthritis. Am J Vet Res 2000;61:900-905.
17. Bau B, Gebhard PM, Haag J, et al. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 2002; 46:2648-2657.
18. Lee JH, Fitzgerald JB, DiMicco MA, et al. Mechanical injury of cartilage explants causes specific time-dependent changes in chondrocyte gene expression. Arthritis Rheum 2005;52:2386-2395.
19. Gelse K, Soder S, Eger W, et al. Osteophyte development - molecular characterization of differentiation stages. Osteoarthritis Cartilage 2003:11;141-148.
20. Chubinskaya S, Kuettner KE, Cole AA. Expression of matrix metalloproteinases in normal and damaged articular cartilage from human knee and ankle joints. Lab Invest 1999;79:1669-1677.
21. Lequerre T, Coulouarn C, Derambure C, et al. A new tool for rheumatology: large-scale analysis of gene expression. Joint Bone Spine 2003;70:248-256.
22. Burgess JK. Gene expression studies using microarrays. Clin Exp Pharmacol Physiol 2001;28:321-328.
23. Sandell LJ. Genes and gene expression. Clin Orthop Relat Res 2000; 379:S9-S16.
24. Aigner T, Zien A, Gehrsitz A, et al. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 2001;44:2777-2789.
25. Aigner T, Zien A, Hanisch D, et al. Gene expression in chondrocytes assessed with use of microarrays. J Bone Joint Surg Am 2003;85-A(suppl 2):117-123.
26. Thornton S, Sowders D, Aronow B, et al. DNA microarray analysis reveals novel gene expression profiles in collagen-induced arthritis. Clin Immunol 2002;105:155-168.
27. Pool RR. Pathologic manifestations of joint disease in the athletic horse. In: McIlwraith CW, Trotter GW, eds. Joint disease in the horse. Philadelphia: WB Saunders Co, 1996;87-104.
28. Palmer JL, Bertone AL. Joint structure, biochemistry and biochemical disequilibrium in synovitis and equine joint disease. Equine Vet J 1994;26:263-277.
29. Buckwalter J. Articular cartilage injuries. Clin Orthop Relat Res 2002;Sep:21-37.
30. American Association of Equine Practitioners Web site. Lameness guide. Available at: www.aaep.org. Accessed Jan 12, 2005.
31. Simmons EJ, Bertone AL, Weisbrode SE. Instability-induced osteoarthritis in the metacarpophalangeal joint of horses. Am J Vet Res 1999;60:7-13.
32. Mankin HJ, Dorfman H, Lippiello L, et al. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971;53:523-537.
33. Baelde HJ, Cleton-Jansen AM, van Beerendonk H, et al. High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma. J Clin Pathol 2001;54:778-782.
34. Gu W, Bertone AL. Generation and performance of an equine-specific large-scale gene expression microarray. Am J Vet Res 2004;65:1664-1673.
35. Zachos TA, Bertone AL. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6. J Orthop Res 2006;24:1279-1291.
36. Li C, Wong WH. DNA-Chip analyzer (dChip). In: Parmigiani G, Garrett ES, Irizarry R, et al, eds. The analysis of gene expression data: methods and software. Springer, NY: Springer Inc, 2003;120-141.
37. van der Sluijs JA, Geesink RG, van der Linden AJ, et al. The reliability of the Mankin score for osteoarthritis. J Orthop Res 1992;10:58-61.
38. Brama PA, TeKoppele JM, Bank RA, et al. Topographical mapping of biochemical properties of articular cartilage in the equine fetlock joint. Equine Vet J 2000;32:19-26.
39. Strauss EJ, Chen CT, Goodrich LR, et al. Biochemical and biomechanical properties of lesion and adjacent articular cartilage after chondral defect repair in an equine model. Am J Sports Med 2005;3:1647-1653.
40. Brommer H, Brama PA, Barneveld A, et al. Differences in the topographical distribution of articular cartilage degeneration between equine metacarpo- and metatarsophalangeal joints. Equine Vet J 2004;36:506-510.
41. van der Harst MR, DeGroot J, Kiers GH, et al. Biochemical analysis of the articular cartilage and subchondral and trabecular bone of the metacarpophalangeal joint of horses with early osteoarthritis. Am J Vet Res 2005;66:1238-1246.
42. Brommer H, van Weeren PR, Brama PAJ, et al. Quantification and age-related distribution of articular cartilage degeneration in the equine fetlock joint. Equine Vet J 2003;35:697-701.
43. Chateau H, Degueurce C, Jerbi H, et al. Normal three dimensional behaviour of the metacarpophalangeal joint and the effect of uneven foot bearing. Equine Vet J Suppl 2001; 33:84-88.
44. Epperly MW, Bernarding M, Gretton J, et al. Overexpression of the transgene for manganese superoxide dismutase (MnSOD) in 32D cl 3 cells prevents apoptosis induction by TNF-alpha, IL-3 withdrawal, and ionizing radiation. Exp Hematol 2003;31:465-474.
45. Trippel SB, Ghivizzani SC, Nixon AJ. Gene-based approaches for the repair of articular cartilage. Gene Ther 2004;11:351-359.
46. Zhang X, Mao Z, Yu C. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10. J Orthop Res 2004;22:742-750.